Thomas Taylor - BC Bud Pres Director
BCBCF Stock | USD 0.05 0.01 10.61% |
Insider
Thomas Taylor is Pres Director of The BC Bud
Age | 38 |
Web | https://thebcbc.com |
Thomas Taylor Latest Insider Activity
Tracking and analyzing the buying and selling activities of Thomas Taylor against BC Bud pink sheet is an integral part of due diligence when investing in BC Bud. Thomas Taylor insider activity provides valuable insight into whether BC Bud is net buyers or sellers over its current business cycle. Note, BC Bud insiders must abide by specific rules, including filing SEC forms every time they buy or sell BC Bud'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Thomas Taylor over three months ago Acquisition by Thomas Taylor of 34198 shares of Floor Decor at 9.99 subject to Rule 16b-3 | ||
Thomas Taylor over three months ago Disposition of 34198 shares by Thomas Taylor of Floor Decor at 9.99 subject to Rule 16b-3 | ||
Thomas Taylor over a year ago Acquisition by Thomas Taylor of 9127 shares of National Vision subject to Rule 16b-3 |
BC Bud Management Efficiency
The company has return on total asset (ROA) of (0.1775) % which means that it has lost $0.1775 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3194) %, meaning that it generated substantial loss on money invested by shareholders. BC Bud's management efficiency ratios could be used to measure how well BC Bud manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Jeff Holm | Biofrontera | N/A | |
Scott Sudduth | Collegium Pharmaceutical | N/A | |
CCFP DipSportMed | Evolus Inc | 60 | |
John Weston | cbdMD Inc | N/A | |
Alex Dasalla | Collegium Pharmaceutical | N/A | |
David Erickson | Evolus Inc | N/A | |
Erica CPA | Biofrontera | 39 | |
Kevin MacDermott | cbdMD Inc | 62 | |
Hermann Lubbert | Biofrontera | 68 | |
Tejinder Virk | Akanda Corp | 42 | |
OriMoni Mimon | INC Research Holdings | 36 | |
Mark Baldyga | Biofrontera | N/A | |
Thomas Flow | Akanda Corp | 46 | |
Sandra Beaver | Evolus Inc | 46 | |
Eugene III | Biofrontera | 39 | |
Elizabeth JD | ANI Pharmaceuticals | N/A | |
BCom BAcc | Akanda Corp | 44 | |
Amos Cohen | INC Research Holdings | 45 | |
Muthusamy RPh | ANI Pharmaceuticals | 56 | |
Marlo Manning | Collegium Pharmaceutical | N/A | |
Matthew Coapman | cbdMD Inc | 48 |
Management Performance
Return On Equity | -0.32 | |||
Return On Asset | -0.18 |
BC Bud Leadership Team
Elected by the shareholders, the BC Bud's board of directors comprises two types of representatives: BC Bud inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BCBCF. The board's role is to monitor BC Bud's management team and ensure that shareholders' interests are well served. BC Bud's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BC Bud's outside directors are responsible for providing unbiased perspectives on the board's policies.
Emily Graham, Chief Officer | ||
Thomas Taylor, Pres Director | ||
Daniel SouthanDwyer, Creative Devel | ||
Brayden Sutton, Chairman CEO |
BCBCF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is BC Bud a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.32 | |||
Return On Asset | -0.18 | |||
Profit Margin | (1.96) % | |||
Operating Margin | (1.82) % | |||
Current Valuation | 1.82 M | |||
Shares Outstanding | 53.02 M | |||
Shares Owned By Insiders | 66.39 % | |||
Price To Book | 3.14 X | |||
Price To Sales | 4.63 X | |||
Revenue | 151 |
Currently Active Assets on Macroaxis
Other Information on Investing in BCBCF Pink Sheet
BC Bud financial ratios help investors to determine whether BCBCF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BCBCF with respect to the benefits of owning BC Bud security.